AVNT AVIENT CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 1122976 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.2%
TTM net income YoY59.0%
TTM EPS YoY58.5%
Revenue 3-yr CAGR2.1%
Net income 3-yr CAGR-32.7%
Margins
Gross margin31.7%
Operating margin9.7%
Net margin5.3%
FCF margin7.0%
EBITDA margin15.3%
Returns
ROE7.5%
ROA3.0%
ROIC (approx.)6.4%
Asset turnover0.57x
Leverage & solvency
Liabilities / assets58.4%
Debt / equity0.74x
Current ratio1.71x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.93x
Accruals ratio-2.8%
Payout ratio55.7%
Capex / revenue3.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.26B | $3.24B |
| Cost of revenue | $2.24B | $2.18B |
| Gross profit | $1.02B | $1.06B |
| R&D expense | $96.70M | $98.70M |
| SG&A expense | $812.10M | $727.40M |
| Operating income | $203.50M | $329.30M |
| Pretax income | $111.70M | $224.80M |
| Income tax | $28.10M | $54.10M |
| Net income | $81.90M | $169.50M |
| EBITDA | $389.40M | $509.00M |
| EPS (basic) | 0.90 | 1.86 |
| EPS (diluted) | 0.89 | 1.84 |
| Dividends declared per share | 1.08 | 1.04 |
| Weighted avg. shares (diluted) | 91.80M | 92.00M |
| Balance sheet | ||
| Cash & equivalents | $510.50M | $544.50M |
| Receivables | $435.00M | $399.50M |
| Inventory | $367.20M | $346.80M |
| Current assets | $1.40B | $1.42B |
| PP&E, net | $988.80M | $955.30M |
| Goodwill | $1.76B | $1.66B |
| Intangibles | $1.49B | $1.45B |
| Total assets | $6.03B | $5.81B |
| Current liabilities | $846.30M | $756.10M |
| Short-term debt | $500,000 | $7.70M |
| Long-term debt | $1.92B | $2.06B |
| Total debt | $1.92B | $2.07B |
| Total liabilities | $3.64B | $3.48B |
| Shareholders' equity | $2.37B | $2.31B |
| Net debt | $1.41B | $1.52B |
| Cash flow statement | ||
| Operating cash flow | $301.60M | $256.80M |
| Capital expenditure | $106.60M | $121.90M |
| Free cash flow | $195.00M | $134.90M |
| Investing cash flow | -$97.00M | -$120.60M |
| Financing cash flow | -$257.10M | -$120.90M |
| Depreciation & amortization | $185.90M | $179.70M |
| Stock-based compensation | $9.10M | $15.40M |
| Dividends paid | $98.80M | $94.00M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.